ProVerum and Zenflow both this week announced FDA approvals for their technologies that treat benign prostatic hyperplasia ...

DUBLIN, Dec. 9, 2025 /PRNewswire/ -- ProVerum Limited, a medical device company focused on innovative, safe and effective solutions for treating benign prostatic hyperplasia (BPH), today announced it ...

U.S. Food and Drug Administration (FDA) approval of the Zenflow Spring(R) Implant and Delivery System for the treatment of symptoms associated with benign prostatic hyperplasia (BPH), also known as ...

GREENBRAE, Calif.--(BUSINESS WIRE)--MarinHealth Medical Center (MHMC) announced today that its surgeons have performed the first Aquablation procedures to treat benign prostatic hyperplasia (BPH).

New BPH module and clinical data reinforce the TULSA Procedure™’s versatility in prostate disease, superior patient benefits, and potential for mainstream adoption ...

Benign prostatic hyperplasia (BPH) is a non-cancerous prostate tissue growth affecting men 40 and older. BPH can cause difficulty urinating and may be exacerbated by some cold and allergy medications.

Mount Sinai Hospital has successfully performed New York City’s first procedure using the HYDROS ™ Robotic System, an advanced technology designed to treat benign prostatic hyperplasia (BPH). This ...

CINCINNATI (WKRC) — A groundbreaking procedure is offering new hope for men suffering from benign prostate hyperplasia (BPH), a condition affecting up to half of all men. Keith Neer, a patient who ...

(RTTNews) - Profound Medical Corp. (PROF), Friday announced the launch of its TULSA-AI Volume Reduction module for benign prostatic hyperplasia (BPH) and the presentation of new clinical data on its ...

IRVINE, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NYMXF) [OTC Markets – NYMXF] (the “Company”) is pleased to announce today that a new formal submission has been ...